DA
AGN

Dunvegan Associates’s Allergan Inc AGN Stock Holding History

Dunvegan Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-34,498
Closed -$3.83M – 219
2013
Q4 		$3.83M Sell
34,498
-999
-3% -$95.4K 3.16% 9
2013
Q3 		$3.21M Sell
35,497
-1,062
-3% -$95.3K 2.37% 15
2013
Q2 		$3.08M Buy
+36,559
New +$3.79M 2.38% 15

Other funds holding AGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dunvegan Associates's AGN Position: Q1 2014 in Review

Dunvegan Associates sold out of Allergan Inc (AGN) in Q1 2014, closing a stake of 34,498 shares — an estimated $3.83M sold.

Dunvegan Associates first reported a position in AGN in Q2 2013 and held it in 3 quarters. The position peaked at $3.83M in Q4 2013. 733 funds tracked by Wall St. Rank hold AGN as of Q1 2014.

  • Dunvegan Associates reported no remaining Allergan Inc position as of Q1 2014 after selling out during the quarter.
  • Dunvegan Associates sold 34,498 Allergan Inc shares in Q1 2014, an estimated $3.83M.
  • Dunvegan Associates first reported a position in Allergan Inc in Q2 2013 and held it in 3 quarters.
  • Dunvegan Associates's Allergan Inc position peaked at $3.83M in Q4 2013.
  • 733 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2014.

Based on Dunvegan Associates's 13F filing for Q1 2014, filed 28 Apr 2017.